REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector
Go back to REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector| (NASDAQ: ABEO) | Delayed: 5.72 -0.03 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.75 | 52 Week High | $9.44 | |||
| Open | $5.68 | 52 Week Low | $2.05 | |||
| Day High | $5.87 | P/E | N/A | |||
| Day Low | $5.67 | EPS | $0.00 | |||
| Volume | 1,015,430 | |||||
| Jennison Natural Resources Fund Class B (NASDAQ: RGNX) | Delayed: 9.95 +0.88 (9.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.07 | 52 Week High | $25.00 | |||
| Open | $8.94 | 52 Week Low | $7.07 | |||
| Day High | $10.34 | P/E | N/A | |||
| Day Low | $8.94 | EPS | $0.00 | |||
| Volume | 2,968,216 | |||||
